Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242].

Ke Hu Wei-Jie Guan Ying Bi Wei Zhang Lanjuan Li Boli Zhang Qingquan Liu Yuanlin Song Xingwang Li Zhongping Duan Qingshan Zheng Zifeng Yang Jingyi Liang Mingfeng Han Lianguo Ruan Chaomin Wu Yunting Zhang Zhen-Hua Jia Nan-Shan Zhong

Phytomedicine

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong province, 510120, China. Electronic address:

Published: January 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805149	PMC
http://dx.doi.org/10.1016/j.phymed.2021.153800	DOI Listing

Publication Analysis

Top Keywords

efficacy safety

safety lianhua

lianhua qingwen

qingwen capsules

capsules repurposed

repurposed chinese

chinese herb

herb patients

patients coronavirus

coronavirus disease

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!